PainReform (PRFX) shares rise 57.62% intraday after announcing name change and expansion into diversified healthcare and AI-driven energy platforms.

PainReform Ltd. surged 57.62% intraday after announcing a name change and strategic expansion into diversified healthcare and AI-driven energy platforms. The pre-market trading session saw a 27.4% jump to $1.02, driven by the corporate rebranding, which signaled a pivot toward ophthalmology (via LayerBio) and energy analytics (via DeepSolar). While technical analysis highlighted low-volume concerns, the broader market's appetite for small-cap speculative plays amplified the move. The expansion aligns with the company's shift from its prior clinical pipeline to diversified growth, though core clinical milestones remain critical for long-term validation.